BioSpace News Archive

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of an expanded label for KEYTRUDA, Merck’s anti-PD-1 therapy

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Stephen “Steve” L. Mayo, professor, California Institute of Technology, will join the company’s Board of Directors effective March 15, 2021

SQZ Biotechnologies (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that the company’s Investigational New Drug (IND) application for SQZTM Activating Antigen Carriers (SQZ AACs) in HPV+ tumors was cleared by the U.S. Food and Drug Administration (FDA).

Fact.MR, a global research and consulting firm, in the updated edition of the report, opines fusionless scoliosis surgery market to propel at a steady pace in 2021 & beyond.

A substantial body of studies have demonstrated beneficial neuroprotective activity of citicoline.

Glass is composed of sand, soda ash cullet, and limestone. The composition of these ingredients varies based on the application of the glass.

The reverse shoulder systems market is anticipated to expand at a considerable pace during the forecast period of 2020-2030.

The single-domain antibody platforms market is prognosticated to invite expansive growth prospects through the assessment period of 2020-2030.

Computational biology has emerged as a discipline in its own right and has enriched the armamentarium of researchers studying molecular mechanism underlying wide range of diseases.

The rising prevalence of mental illnesses and depression cases, coupled with the increasing awareness about the same is expected to aid in expansion of the global magnetoencephalography market during the forecast period, 2020 to 2030.